Ca16Mab-56, a Novel Anti-Cadherin-16/Ksp-Cadherin Monoclonal Antibody for Multiple Applications
Open Access
- 7 September 2026
- journal article
- research article
- Published by MDPI AG in Antibodies
- Vol. 15 (5) , 83
Abstract
Background/Objectives: Cadherin-16 (CDH16, Ksp-cadherin) possesses unique seven extracellular cadherin repeats, and its expression is restricted to normal kidney epithelium. CDH16 is downregulated in renal cell carcinoma (RCC) and is associated with poor prognosis. Therefore, developing mAbs that specifically recognize cell-surface CDH16 is essential for tumor diagnosis and for isolating CDH16-positive renal epithelial cells. Methods: Anti-human CDH16 mAbs (designated as Ca16Mabs) were developed by immunizing mice with CDH16-overexpressed tumor cells, followed by a high-throughput flow cytometry-based screening. Results: Among the 58 established Ca16Mabs, a clone, Ca16Mab-56 (IgG1, κ), specifically recognized CDH16-overexpressed Chinese hamster ovary-K1 (CHO/CDH16) cells with no detectable cross-reactivity to 21 other CDHs in flow cytometry. Ca16Mab-56 also detected endogenous CDH16 in human RCC cell lines (OS-RC-2 and KMRC-20) and normal kidney epithelial cell lines. The dissociation constant (KD) values of Ca16Mab-56 for CHO/CDH16 and OS-RC-2 were determined as 6.5 × 10−9 M and 1.2 × 10−9 M, respectively. Furthermore, Ca16Mab-56 detected endogenous CDH16 by Western blotting and showed potent staining in normal kidney tubular epithelium and clear membranous staining in renal cell carcinoma in immunohistochemistry. Conclusions: Ca16Mab-56 is a versatile tool for detecting CDH16 and has potential for tumor diagnosis.Keywords
All Related Versions
Funding Information
- Japan Agency for Medical Research and Development (JP26am0521010)
- Japan Agency for Medical Research and Development (JP26ama121008)
- Japan Agency for Medical Research and Development (JP25ama221153)
- Japan Agency for Medical Research and Development (JP25ama221339)
- Japan Society for the Promotion of Science (25K10553)
- Japan Society for the Promotion of Science (26K02289)
This publication has 53 references indexed in Scilit:
- Development of novel anti-CDH1/E-cadherin monoclonal antibodies for versatile applicationsBiochemistry and Biophysics Reports, 2025
- Development of an anti-CDH15/M-cadherin monoclonal antibody Ca15Mab-1 for flow cytometry, immunoblotting, and immunohistochemistryBiochemistry and Biophysics Reports, 2025
- CDH17-targeting CAR-NK cells synergize with CD47 blockade for potent suppression of gastrointestinal cancersActa Pharmaceutica Sinica B, 2025
- Renal proximal tubular epithelial cells: review of isolation, characterization, and culturing techniquesMolecular Biology Reports, 2020
- Engineered renal tissue as a potential platform for pharmacokinetic and nephrotoxicity testingDrug Discovery Today, 2014
- Tissue-engineered kidney disease modelsAdvanced Drug Delivery Reviews, 2014
- Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma #Hepatology, 2009
- Molecular evolution of the cadherin superfamilyThe International Journal of Biochemistry & Cell Biology, 2009
- Unique gene structure and paralogy define the 7D-cadherin familyCellular and Molecular Life Sciences, 2006
- Transgenic mice expressing tamoxifen‐inducible Cre for somatic gene modification in renal epithelial cellsGenesis, 2006